Advertisement

Index by author

February 01, 2022; Volume 380,Issue 2

  1. Becktel, Danielle A.

    1. Open Access
      Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery
      Thuy-Vi V. Nguyen, Rachel H. Crumpacker, Kylie E. Calderon, Frankie G. Garcia, Jacob C. Zbesko, Jennifer B. Frye, Selena Gonzalez, Danielle A. Becktel, Tao Yang, Marco A. Tavera-Garcia, Helena W. Morrison, Rick G. Schnellmann, Frank M. Longo and Kristian P. Doyle
      Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 126-141; DOI: https://doi.org/10.1124/jpet.121.000711

  2. Brouwer, Kim L. R.

    1. Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors
      Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors
      Chitra Saran, Louise Sundqvist, Henry Ho, Jonna Niskanen, Paavo Honkakoski and Kim L. R. Brouwer
      Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 114-125; DOI: https://doi.org/10.1124/jpet.121.000828

  3. Calderon, Kylie E.

    1. Open Access
      Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery
      Thuy-Vi V. Nguyen, Rachel H. Crumpacker, Kylie E. Calderon, Frankie G. Garcia, Jacob C. Zbesko, Jennifer B. Frye, Selena Gonzalez, Danielle A. Becktel, Tao Yang, Marco A. Tavera-Garcia, Helena W. Morrison, Rick G. Schnellmann, Frank M. Longo and Kristian P. Doyle
      Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 126-141; DOI: https://doi.org/10.1124/jpet.121.000711

  4. Canning, Brendan J.

    1. Evidence for Alpha7 Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough
      Brendan J. Canning, Qi Liu, Mayuko Tao, Robert DeVita, Michael Perelman, Douglas W. Hay, Peter V. Dicpinigaitis and Jing Liang
      Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 94-103; DOI: https://doi.org/10.1124/jpet.121.000641

  5. Cloyd, James C.

    1. Intravenous and Intramuscular Allopregnanolone for Early Treatment of Status Epilepticus: Pharmacokinetics, Pharmacodynamics, and Safety in Dogs
      Irene Vuu, Edward E. Patterson, Chun-Yi Wu, Dorota Zolkowska, Ilo E. Leppik, Michael A. Rogawski, Gregory A. Worrell, Vaclav Kremen, James C. Cloyd and Lisa D. Coles
      Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 104-113; DOI: https://doi.org/10.1124/jpet.121.000736

  6. Coles, Lisa D.

    1. Intravenous and Intramuscular Allopregnanolone for Early Treatment of Status Epilepticus: Pharmacokinetics, Pharmacodynamics, and Safety in Dogs
      Irene Vuu, Edward E. Patterson, Chun-Yi Wu, Dorota Zolkowska, Ilo E. Leppik, Michael A. Rogawski, Gregory A. Worrell, Vaclav Kremen, James C. Cloyd and Lisa D. Coles
      Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 104-113; DOI: https://doi.org/10.1124/jpet.121.000736

  7. Crumpacker, Rachel H.

    1. Open Access
      Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery
      Thuy-Vi V. Nguyen, Rachel H. Crumpacker, Kylie E. Calderon, Frankie G. Garcia, Jacob C. Zbesko, Jennifer B. Frye, Selena Gonzalez, Danielle A. Becktel, Tao Yang, Marco A. Tavera-Garcia, Helena W. Morrison, Rick G. Schnellmann, Frank M. Longo and Kristian P. Doyle
      Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 126-141; DOI: https://doi.org/10.1124/jpet.121.000711

  8. Devita, Robert

    1. Evidence for Alpha7 Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough
      Brendan J. Canning, Qi Liu, Mayuko Tao, Robert DeVita, Michael Perelman, Douglas W. Hay, Peter V. Dicpinigaitis and Jing Liang
      Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 94-103; DOI: https://doi.org/10.1124/jpet.121.000641

  9. Dicpinigaitis, Peter V.

    1. Evidence for Alpha7 Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough
      Brendan J. Canning, Qi Liu, Mayuko Tao, Robert DeVita, Michael Perelman, Douglas W. Hay, Peter V. Dicpinigaitis and Jing Liang
      Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 94-103; DOI: https://doi.org/10.1124/jpet.121.000641

  10. Doyle, Kristian P.

    1. Open Access
      Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery
      Thuy-Vi V. Nguyen, Rachel H. Crumpacker, Kylie E. Calderon, Frankie G. Garcia, Jacob C. Zbesko, Jennifer B. Frye, Selena Gonzalez, Danielle A. Becktel, Tao Yang, Marco A. Tavera-Garcia, Helena W. Morrison, Rick G. Schnellmann, Frank M. Longo and Kristian P. Doyle
      Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 126-141; DOI: https://doi.org/10.1124/jpet.121.000711
« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top

In this issue

Advertisement